Shareholders' equity · 2011–2025
Alnylam Pharmaceuticals shareholders' equity
$789M+1,076.3% · FY2025
Alnylam Pharmaceuticals (ALNY) reported $789M in shareholders' equity for fiscal 2025, +1,076.3% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $789M | +1,076.3% | Open → |
| FY20242024-12-31 | $67.1M | +$288M | Open → |
| FY20232023-12-31 | −$221M | −$62.4M | Open → |
| FY20222022-12-31 | −$158M | −$746M | Open → |
| FY20212021-12-31 | $588M | −42.1% | Open → |
| FY20202020-12-31 | $1.0B | −29.4% | Open → |
| FY20192019-12-31 | $1.4B | +10.5% | Open → |
| FY20182018-12-31 | $1.3B | −26.3% | Open → |
| FY20172017-12-31 | $1.8B | +92.0% | Open → |
| FY20162016-12-31 | $920M | −27.2% | Open → |
| FY20152015-12-31 | $1.3B | +35.1% | Open → |
| FY20142014-12-31 | $936M | +246.3% | Open → |
| FY20132013-12-31 | $270M | +101.7% | Open → |
| FY20122012-12-31 | $134M | +13.6% | Open → |
| FY20112011-12-31 | $118M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +14.5%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Alnylam Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/alnylam-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Alnylam Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/alnylam-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-alnylam-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Alnylam Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/alnylam-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001178670-26-000062 · July 30, 2026
{{cite web |title=Alnylam Pharmaceuticals shareholders' equity — 10-Q (0001178670-26-000062) |url=https://www.sec.gov/Archives/edgar/data/1178670/000117867026000062/alny-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-30}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.